From bench to bedside: Nintedanib for progressive fibrosing interstitial lung diseases

15:30 - 15:36

Speaker: Lutz Wollin

Baseline inflammatory markers and survival in patients with interstitial lung disease

15:36 - 15:42

Speaker: Monica Hatch

Differentiating between depression, anxiety and a grief reaction: Tricky times for most IPF patients, their caregivers and their care team

15:42 - 15:48

Speaker: Debra Sandford

Predicting fitness to fly in interstitial lung disease

15:48 - 15:54

Speaker: Prem Bhoey

Portable oxygen concentrator for delivery of ambulatory oxygen in interstitial lung disease - a crossover trial

15:54 - 16:00

Speaker: Mariana Hoffman

The clinical impact of self-reported symptoms of chronic rhinosinusitis on quality of life in adults with bronchiectasis

16:00 - 16:06

Speaker: Annemarie Lee

Current Australian and New Zealand physiotherapy practices in the use of airway clearance techniques in the management of individuals experiencing an acute exacerbation of bronchiectasis

16:06 - 16:12

Speaker: Jennifer Phillips

ILD MDM in clinical practice - an audit

16:12 - 16:18

Speaker: Kah Ann Ho

Nintedanib: Effects on extracellular matrix turnover biomarkers in idiopathic pulmonary fibrosis

16:18 - 16:24

Speaker: Helen Jo